Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry succeeding him as the interim chief executive officer, effective immediately.

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is ...

(RTTNews) - Consumer health company Kenvue, Inc. (KVUE) announced Monday that its Board of Directors has appointed Kirk Perry as Interim Chief Executive Officer, effective immediately.

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its struggling skin health and beauty unit which includes brands like Neutrogena ...

Kenvue Inc. (NYSE:KVUE) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company names an interim CEO and ...

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson ...

Kenvue said Monday that board member Kirk Perry will serve as interim CEO, effective immediately. Perry has served as a director since December and most recently served as CEO of Circana, a ...

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut ...

The basics: CEO Thibaut Mongon departs; Kirk Perry named interim leader Board launches strategic review to explore business options Perry brings 30+ years of global CPG, tech experience ...

Kenvue named director Kirk Perry as interim CEO, while Mongon also stepped down from the board. Perry, who worked at Procter & Gamble (PG.N) for 23 years, most recently served as CEO of technology ...

Kenvue CEO Thibaut Mongon has stepped down as the company’s chief executive and departed its board of directors. The CEO of Tylenol maker Kenvue ( KVUE) has left the company as part of an internal ...